Personal Genome Diagnostics (PGDx) creates clarity for patients with cancer and their clinicians by removing barriers to precision oncology testing in order to make timely, personalized cancer treatments a reality for all. We unlock a deeper understanding of tumor biology to drive biomarker-informed treatment plans by enabling in-house tumor profiling with our portfolio of RUO and IVD tissue, liquid biopsy-based genomic products, and robust bioinformatics because all patients deserve a chance to lead their best lives.